Medications

Study finds common antibiotic azithromycin carries heart risk

Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...

Diseases, Conditions, Syndromes

Addition of zinc may benefit some being treated for COVID-19

(HealthDay)—For hospitalized patients with COVID-19, the addition of zinc sulfate to hydroxychloroquine and azithromycin may improve some outcomes, according to a study not yet peer reviewed and posted on medRxiv.org.

page 2 from 8